HLA-C and neoplasm: To systematically assess tumor immunogenicity, we further calculated the immunophenoscore (IPS), developed in a previous study, to present the overall score for immune response[31] based on the expression of the gene sets or representative genes for four immune categories, including effector cells, suppressor cells, major histocompatibility complex (MHC) molecules, and immunomodulators (see Methods).